Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

Jay H. Traverse, Timothy D. Henry, Douglas Vaughn, Stephen G. Ellis, Carl J. Pepine, James T. Willerson, David Zhao, Linda B. Piller, Marc S. Penn, Barry J. Byrne,

American Heart Journal · 2009 · 77 citations · 19 references

Concepts

References

19